化疗联合复方皂矾丸在中晚期原发性肝癌患者中的临床效果研究  

Study on clinical effect of chemotherapy combined with compound Zaofan pill in patients with primary liver cancer of middle and advanced stage

作　　者：孙钦文 梁蓝月 孙成晖 麦茂 严伟红 SUN Qin-wen;LIANG Lan-yue;SUN Cheng-hui;et al(Guangdong Yangchun People＇ s Hospital, Yangchun 529600, Chin)

机构地区：[1]广东省阳春市人民医院,529600

出　　处：《中国实用医药》2018年第12期79-80,共2页China Practical Medicine

摘　　要：目的探究化疗联合复方皂矾丸在中晚期原发性肝癌患者中的临床效果。方法 58例中晚期原发性肝癌患者,根据治疗方法不同分为对照组和研究组,各29例。对照组患者采用单纯化疗治疗,研究组患者采用化疗联合复方皂矾丸治疗,比较两组临床治疗效果及不良反应情况。结果研究组患者治疗总有效率为58.62%,对照组患者治疗总有效率为31.03%,研究组总有效率高于对照组,差异有统计学意义(P<0.05)。研究组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论在化疗的基础上联合复方皂矾丸治疗中晚期原发性肝癌,对促进临床疗效的提升、降低不良反应发生率具有积极意义,临床推广价值较高。Objective To investigate the clinical effect of chemotherapy combined with compound Zaofan pill in patients with primary liver cancer of middle and advanced stage. Methods A total of 58 patients with primary liver cancer of middle and advanced stage were divided by different treatment methods into control group and research group, with 29 cases in each group. The control group received chemotherapy only, and the research group received chemotherapy combined with compound Zaofan pill. Comparison were made on therpeutic effect, incidence of adverse reactions in two groups. Results The research group had total treatment effective rate as 58.62%, which was 31.03% in the control group. The research group had higher total effective rate than the control group, and the difference was statistically significant（P〈0.05）. The research group had lower incidence of adverse reactions than the control group, and the difference was statistically significant（P〈0.05）. Conclusion On the basis of chemotherapy, compound Zaofan pill shows positive significance in promoting the clinical efficacy and reducing the incidence of adverse reactions. It contains a high clinical promotion value.

关 键 词：原发性肝癌 中晚期 复方皂矾丸 化疗 

分 类 号：R735.7[医药卫生—肿瘤]